- Rosenthal E, Sala F, Chichmanian RM, Batt M, Cassuto JP. Ergotism related to concurrent administration of ergotamine tartrate and indinavir. JAMA 1999; 281: 987.
- Dresser GK, Spence JD, Bailey DG. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin Pharmacokinet 2000; 38: 41–57.
- Nahata M. Drug interactions with azithromycin and the macrolides: an overview. J Antimicrob Chemother 1996; 37 (Suppl C): 133–42.
- Amsden GW. Macrolides versus azalides: a drug interaction update. Ann Pharmacother 1995; 29: 906–17.
- Periti P, Mazzei T, Mini E, Novelli A. Pharmacokinetic drug interactions of macrolides. Clin Pharmacokinet 1992; 23: 10631.
- Rapp RP. Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactions. Ann Pharmacother 1998; 32: 785–93.
- Blanche P, Rigolet A, Gombert B, Ginsburg C, Salmon D, Sicard D. Ergotism related to a single dose of ergotamine tartrate in an AIDS patient treated with ritonavir. Postgrad Med J 1999; 75: 546–7.
- Montero A, Giovanonni A, Tvrde P. Leg ischemia in a patient receiving ritonavir and ergotamine. Ann Intern Med 1999; 130: 329.
- Liaudet L. Severe ergotism associated with interaction between ritonavir and ergotamine. Br Med J 1999; 318: 771.
- Caballero-Granado FJ, Viciana P, Cordero E, Gomez-Vera MJ, del Nozal M, Lopez-Cortes. Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient. Antimicrob Agents Chemother 1997; 41: 1207.
Scandinavian Journal of Infectious Diseases
Volume 33, 2001 - Issue 10